Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

Abstract Background Respiratory syncytial virus (RSV) causes a substantial burden of acute lower respiratory infection in children under 5 years, particularly in low- and middle-income countries (LMICs). Maternal vaccine (MV) and next-generation monoclonal antibody (mAb) candidates have been shown t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mihaly Koltai, Jocelyn Moyes, Bryan Nyawanda, Joyce Nyiro, Patrick K. Munywoki, Stefano Tempia, Xiao Li, Marina Antillon, Joke Bilcke, Stefan Flasche, Philippe Beutels, D. James Nokes, Cheryl Cohen, Mark Jit
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-03-01
coleção:	BMC Medicine
Assuntos:	Respiratory syncytial virus Cost-effectiveness analysis Maternal vaccination Monoclonal antibodies Disease burden Hospital data
Acesso em linha:	https://doi.org/10.1186/s12916-023-02806-w
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!